MedAlliance has announced the completion of patient enrolment in the PRISTINE clinical trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of patients...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create...
The study will look at how intensive non-surgical periodontal therapy and home dental hygiene impact overall health.
Alphabet’s life science subsidiary Verily is teaming up...
The trial is the first study to compare interventional therapy in combination with anticoagulation vs. anticoagulation alone for pulmonary embolism.
A new study using Boston Scientific's EkoSonic...
CartiHeal Ltd, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, which was granted Breakthrough Device...
One of the world’s leading centres in gastroenterology has concluded a clinical trial to investigate the use of a remote-monitoring device and app to...
They will highlight the application of digital cardiac rehabilitation in cardio-oncology.
Queensland-based digital health firm Cardihab and Baker Heart and Diabetes Institute, a medical research...
Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announces study results showing patients treated with just its REGENETEN Bioinductive Implant for partial-thickness rotator cuff...
-- Non-Invasive Alternative Outperformed Conventional Tests with Greater Sensitivity and Speed in 111-Person Study --
-- Technology-Integrated Magneto-Electronic Sensing (TiMES) Digital Diagnostic Platform Has Potential...
